{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:47:15Z","timestamp":1791978435408,"version":"4.4.0"},"reference-count":40,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T00:00:00Z","timestamp":1726963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation of Korea (NRF)","award":["NRF-2020R1A2C100691511"],"award-info":[{"award-number":["NRF-2020R1A2C100691511"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Head and neck squamous cell carcinoma (HNSC) is the most prevalent cancer in the head and neck region, originating from the mucosal epithelium of the oral cavity, pharynx, and larynx. The solute carrier (SLC) transporter superfamily, consisting of over 400 proteins across 65 families, plays a crucial role in cellular functions and presents promising targets in precision oncology. This study aims to analyze the expression of SLC transporters in HNSC and their potential as biomarkers and therapeutic targets. Methods: We leveraged mRNA and protein expression data from The Cancer Genome Atlas (TCGA) and The Human Protein Atlas (HPA) to examine SLC transporter expression in HNSC. Gene Set Enrichment Analysis (GSEA) was conducted to assess the involvement of SLC transporters in various oncogenic pathways. Results: Significant upregulation of SLC transporters was observed in tumor tissues compared to normal tissues, with notable increases in SLC16A3, SLC53A1, SLC25A32, and SLC2A3. This upregulation correlated with poorer overall survival (OS) and disease-specific survival (DSS). GSEA revealed that these transporters are significantly involved in critical oncogenic pathways, including epithelial-mesenchymal transition (EMT), angiogenesis, and hypoxia, which are vital for cancer progression and metastasis. Conclusions: The study identifies SLC transporters as potential biomarkers and therapeutic targets in HNSC. Targeting these transporters with small molecule inhibitors could disrupt essential supply routes for cancer cells, enhancing treatment efficacy and improving patient outcomes. This study paves the way for developing SLC-based target therapies in precision oncology, with the goal of improving survival rates for patients with HNSC.<\/jats:p>","DOI":"10.3390\/cancers16183226","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T09:15:07Z","timestamp":1727082907000},"page":"3226","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Solute Carrier (SLC) Transporter Superfamily as Therapeutic Targets for the Treatment of Head and Neck Squamous Cell Carcinoma"],"prefix":"10.3390","volume":"16","author":[{"given":"Sang Yeon","family":"Cho","sequence":"first","affiliation":[{"name":"Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea"},{"name":"CHOMEDICINE Inc., TIPS Town, Chungnam National University, Daejeon 34135, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Sook","family":"Kang","sequence":"additional","affiliation":[{"name":"Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/pcmedi\/pbz016","article-title":"Targeting cancer stem cells in squamous cell carcinoma","volume":"2","author":"Chen","year":"2019","journal-title":"Precis. Clin. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Network (2015). Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature, 517, 576\u2013582.","DOI":"10.1038\/nature14129"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40425-019-0662-5","article-title":"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)","volume":"7","author":"Cohen","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Puris, E., Fricker, G., and Gynther, M. (2023). The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020364"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101952","DOI":"10.1016\/j.molmet.2024.101952","article-title":"Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy","volume":"84","author":"Hushmandi","year":"2024","journal-title":"Mol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.annonc.2021.11.004","article-title":"A state-of-the-art review of stratified medicine in cancer: Towards a future precision medicine strategy in cancer","volume":"33","author":"Middleton","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13073-015-0203-x","article-title":"Next-generation sequencing to guide cancer therapy","volume":"7","author":"Gagan","year":"2015","journal-title":"Genome Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"238045","DOI":"10.1155\/2014\/238045","article-title":"Advances in Proteomic Technologies and Its Contribution to the Field of Cancer","volume":"2014","author":"Mesri","year":"2014","journal-title":"Adv. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A Call for Systematic Research on Solute Carriers","volume":"162","author":"Snijder","year":"2015","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: Emerging opportunities","volume":"14","author":"Lin","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1002\/ctm2.356","article-title":"Emerging roles of the solute carrier family in pancreatic cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"D812","DOI":"10.1093\/nar\/gku1073","article-title":"The UCSC Cancer Genomics Browser: Update 2015","volume":"43","author":"Goldman","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tran, A.N., Dussaq, A.M., Kennell, T., Willey, C.D., and Hjelmeland, A.B. (2019). HPAanalyze: An R package that facilitates the retrieval and analysis of the Human Protein Atlas data. BMC Bioinform., 20.","DOI":"10.1186\/s12859-019-3059-z"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Budczies, J., Klauschen, F., Sinn, B.V., Gyorffy, B., Schmitt, W.D., Darb-Esfahani, S., and Denkert, C. (2012). Cutoff Finder: A comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051862"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"eadg7492","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1021\/acs.jmedchem.9b01237","article-title":"The Druggability of Solute Carriers","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.mam.2012.05.013","article-title":"Characteristics of mammalian Rh glycoproteins (SLC42 transporters) and their role in acid-base transport","volume":"34","author":"Nakhoul","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.mam.2012.05.005","article-title":"The mitochondrial transporter family SLC25: Identification, properties and physiopathology","volume":"34","author":"Palmieri","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tibs.2019.11.001","article-title":"The SLC25 Mitochondrial Carrier Family: Structure and Mechanism","volume":"45","author":"Ruprecht","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family-structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","article-title":"Metabolites and the tumour microenvironment: From cellular mechanisms to systemic metabolism","volume":"3","author":"Elia","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e007349","DOI":"10.1136\/jitc-2023-007349","article-title":"MCT4 blockade increases the efficacy of immune checkpoint blockade","volume":"11","author":"Babl","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/acs.jmedchem.2c01342","article-title":"Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology","volume":"66","author":"Goldberg","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Yan, R., Chen, H., Liu, C., Zhao, J., Wu, D., Jiang, J., Gong, J., and Jiang, D. (2024). Human XPR1 structures reveal phosphate export mechanism. Nature.","DOI":"10.1038\/s41586-024-07852-9"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.physiol.69.040705.141729","article-title":"Phosphatonins and the regulation of phosphate homeostasis","volume":"69","author":"Berndt","year":"2007","journal-title":"Annu. Rev. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1073\/pnas.1908830117","article-title":"Control of XPR1-dependent cellular phosphate efflux by InsP(8) is an exemplar for functionally-exclusive inositol pyrophosphate signaling","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/cas.15358","article-title":"PHOSPHATE exporter XPR1\/SLC53A1 is required for the tumorigenicity of epithelial ovarian cancer","volume":"113","author":"Hayashi","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13046-019-1155-6","article-title":"Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-kappaB signaling","volume":"38","author":"Chen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"31480","DOI":"10.1074\/jbc.M111.272187","article-title":"Tetrahydrofolate recognition by the mitochondrial folate transporter","volume":"286","author":"Lawrence","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cmet.2020.12.002","article-title":"Tumor Reliance on Cytosolic versus Mitochondrial One-Carbon Flux Depends on Folate Availability","volume":"33","author":"Lee","year":"2021","journal-title":"Cell Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ryniawec, J.M., Coope, M.R., Loertscher, E., Bageerathan, V., de Oliveira Pessoa, D., Warfel, N.A., Cress, A.E., Padi, M., and Rogers, G.C. (2022). GLUT3\/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors. Diagnostics, 12.","DOI":"10.3390\/diagnostics12030676"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wu, W.Z., and Bai, Y.P. (2023). Endothelial GLUTs and vascular biology. Biomed. Pharmacother., 158.","DOI":"10.1016\/j.biopha.2022.114151"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2049-3002-2-11","article-title":"GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer","volume":"2","author":"Masin","year":"2014","journal-title":"Cancer Metab."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/18\/3226\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:02:06Z","timestamp":1760112126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/18\/3226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,22]]},"references-count":40,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["cancers16183226"],"URL":"https:\/\/doi.org\/10.3390\/cancers16183226","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,22]]}}}